Share Twitter LinkedIn Facebook Email Michael R. Harrison, MD Associate Professor of Medicine Duke Cancer Institute discusses Active Surveillance for Favorable Risk mRCC at the 18th International Kidney Cancer Symposium 2019, Miami, FL.